Thomas Albrecht

11PUBLICATIONS
39CO-AUTHORS
Cancer cell biologyCancer geneticsImmunogenetics (incl. genetic immunology)Separation technologiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 21, 2024
Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma.

Kaiyu Xu, Annika Kessler, Federico Nichetti

|Jul 05, 2024
Whole-exome sequencing reveals novel cancer genes and actionable targets in biliary tract cancers in primary sclerosing cholangitis.

Marit M Grimsrud, Michael Forster, Benjamin Goeppert

|May 15, 2024
Combined analysis of albumin in situ hybridisation and C reactive protein immunohistochemistry for the diagnosis of intrahepatic cholangiocarcinoma: towards a molecular classification paradigm.

Thomas Albrecht, Annik Rossberg, Fabian Rose

|Dec 22, 2023
Chromosome 8p engineering reveals increased metastatic potential targetable by patient-specific synthetic lethality in liver cancer.

Thorben Huth, Emely C Dreher, Steffen Lemke

|Aug 19, 2022
Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma.

Paula Hoffmeister-Wittmann, Andreas Mock, Federico Nichetti

|May 31, 2022
Influence of carnosine and carnosinase-1 on diabetes-induced afferent arteriole vasodilation: implications for glomerular hemodynamics.

Angelica Rodriguez-Niño, Diego O Pastene, Steffen A Hettler

Pageof 2

Frequent Collaborators

7 joint publications

Stephanie Roessler

4 joint publications

Benjamin Goeppert

2 joint publications

Peter Schirmacher

2 joint publications

Fritz Brinkmann